224
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

The Efficacy of Topical Formulation Containing Ciplukan (Physalis angulata Linn.) in Modulating Interleukin-17 and Interferon Gamma Expression in Mice (Mus musculus) Psoriasis Model

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 367-374 | Received 26 Jun 2023, Accepted 02 Oct 2023, Published online: 09 Oct 2023

References

  • Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffel DJ, Wolff K. Fitzpatrick’s Dermatology. 8th ed. New York: McGraw-Hill Education; 2008.
  • Bolognia JL, Jorizzo JL, Schaffer JV. Dermatology. 3rd ed. Edinburgh: Mosby Elsevier; 2008.
  • Ogawa E, Sato Y, Minagawa A, Okuyama R. Pathogenesis of psoriasis and development of treatment. J Dermatol. 2018;45:264–272. doi:10.1111/1346-8138.14139
  • Raychaudhuri SP, Raychaudhuri S, Bagchi D. Psoriasis and Psoriatic Arthritis Pathophysiology, Therapeutic Intervention and Complementary Medicine. 1st ed. Boca Raton: CRC Press; 2018:3–8.
  • Dewi DAPN, Indira IG. Insiden dan profil psoriasis di poliklinik kulit dan kelamin Rumah Sakit Umum Pusat Sanglah Denpasar periode Januari 2012 sampai Desember 2014 [Incidence and profile of psoriasis in dermatovenereology clinic at Sanglah Central General Hospital Denpasar in January 2012 to December 2014]. E J Med Udayana. 2018;7(9):1–7. Indonesian.
  • Fitch E, Harper E, Skorcheva I, Kurtz SE, Blauvelt A. Pathophysiology of psoriasis: recent advances on IL-23 and TH17 cytokines. Curr Rheumatol Rep. 2007;9:461–467. doi:10.1007/s11926-007-0075-1
  • Traub M, Marshall K. Psoriasis-pathophysiology, conventional, and alternative treatment approaches. Alter Med Rev. 2007;12:319–330.
  • Vecellio M, Hake VX, Davidson C, Carena MC, Wordsworth BP, Selmi C. The IL-17/IL-23 axis and its genetic contribution to psoriatic arthritis. Front Immunol. 2021;11. doi:10.3389/fimmu.2020.596086
  • Lowes MA, Suárez-Fariñas M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014;32:227–255. doi:10.1146/annurev-immunol-032713-120225
  • Chiricozzi A, Guttman-Yassky E, Suárez-Farĩas M, et al. Integrative responses to IL-17 and TNF-α in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis. J Invest Dermatol. 2011;131(3):677–687. doi:10.1038/jid.2010.340
  • Kang S, Amagai M, Bruckner AL, et al. Fitzpatrick’s Dermatology. 9th ed. McGraw-Hill Education; 2019.
  • Griffiths CEM, Barker J, Bleiker TO, Chalmers R, Creamer D. Rooks’s Textbook of Dermatology. 9th ed. Cambridge: Wiley-Balckwell; 2016.
  • Kusumaningtyas R, Laily N, Limandha P. Potential of ciplukan (Physalis Angulata L.) as source of functional ingredient. Procedia Chem. 2015;14:367–372. doi:10.1016/j.proche.2015.03.050
  • Sun CP, Qiu CY, Yuan T, et al. Antiproliferative and anti-inflammatory withanolides from physalis angulata. J Nat Prod. 2016;79(6):1586–1597. doi:10.1021/acs.jnatprod.6b00094
  • Murali Krishna T, Vadluri R, Manoj Kumar E. In vitro determination of the antioxidant activity of physalis angulata lnn. Int J Pharma Bio Sci. 2013;4(3):1.
  • Dewi S, Isbagio H, Purwaningsih EH, Kertia N, Setiabudy R, Setiati S. A double-blind, randomized controlled trial of ciplukan (Physalis angulata Linn) extract on skin fibrosis, inflammatory, immunology, and fibrosis biomarkers in scleroderma patients. Acta Med Indones. 2019;51(4):303–310.
  • Li Q, Liu W, Gao S, Mao Y, Xin Y. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist. BMC Immunol. 2021;22(1). doi:10.1186/s12865-021-00401-3
  • Nguyen DT, Ton NL, Nguyen HP, Nguyen DC, Van Ly A, Nguyen TT. Chemical constituents of Physalis angulata L. (family solanaceae). Can Tho Univ J Sci. 2016;2:1.
  • Soares MBP, Bellintani MC, Ribeiro IM, Tomassini TCB, Ribeiro Dos Santos R. Inhibition of macrophage activation and lipopolysaccaride-induced death by seco-steroids purified from Physalis angulata L. Eur J Pharmacol. 2003;459(1):107–112. doi:10.1016/S0014-2999(02)02829-7
  • Rengifo-Salgado E, Vargas-Arana G. Physalis angulata L. (Bolsa mullaca): a review of its traditional uses, chemistry and pharmacology. Bol Latinoam Caribe Plantas Med Aromat. 2013;12(5):1.
  • Mahalakshmi A, NIdavani R. Physalis Angulata L.: an ethanopharmacological review. Indo Am J Pharm Res. 2014;4(3):1.
  • Bastos GNT, Silveira AJA, Salgado CG, Picanço-Diniz DLW, Do Nascimento JLM. Physalis angulata extract exerts anti-inflammatory effects in rats by inhibiting different pathways. J Ethnopharmacol. 2008;118(2):246–251. doi:10.1016/j.jep.2008.04.005
  • Kwatra G, Mukhopadhyay S. Topical corticosteroids: pharmacology. In: A Treatise on Topical Corticosteroids in Dermatology: Use, Misuse and Abuse. Springer; 2017.
  • Uva L, Miguel D, Pinheiro C, et al. Mechanisms of action of topical corticosteroids in psoriasis. Int J Endocrinol. 2012;2012:1–16. doi:10.1155/2012/561018
  • Chen H, Lu C, Liu H, et al. Quercetin ameliorates imiquimod-induced psoriasis-like skin inflammation in mice via the NF-κB pathway. Int Immunopharmacol. 2017;48:110–117. doi:10.1016/j.intimp.2017.04.022
  • Ukwubile CA, Oise IE. Analgesic and anti-inflammatory activity of Physalis angulata Linn. (Solanaceae) leaf methanolic extract in swiss albino mice. Int Biol Biomed J. 2016;2(4):1.
  • Di Meglio P, Duarte JH. CD8 T cells and IFN-γ emerge as critical players for psoriasis in a novel model of mouse psoriasiform skin inflammation. J Investig Dermatol. 2013;133:871–874. doi:10.1038/jid.2012.426
  • Torti DC, Feldman SR. Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol. 2007;57:1059–1068. doi:10.1016/j.jaad.2007.07.016
  • Huang S. Comprehensive dermatologic drug therapy. Skin Med. 2022;20:1.
  • Pinto NB, Morais TC, Carvalho KMB, et al. Topical anti-inflammatory potential of Physalin E from Physalis angulata on experimental dermatitis in mice. Phytomedicine. 2010;17(10):740–743. doi:10.1016/j.phymed.2010.01.006